ConvaTec Group (OTCMKTS:CNVVY – Get Free Report) was downgraded by research analysts at Royal Bank of Canada from a “moderate buy” rating to a “hold” rating in a research report issued to clients and investors on Monday,Zacks.com reports.
Separately, Peel Hunt raised ConvaTec Group from a “hold” rating to a “moderate buy” rating in a research report on Monday, April 14th. One equities research analyst has rated the stock with a hold rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Strong Buy”.
Check Out Our Latest Research Report on CNVVY
ConvaTec Group Stock Down 0.7%
ConvaTec Group Company Profile
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
See Also
- Five stocks we like better than ConvaTec Group
- Financial Services Stocks Investing
- Among the Market’s Most Shorted: 2 Firms With +40% Short Interest
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next
- Pros And Cons Of Monthly Dividend Stocks
- Rocket Lab Expands Into Payloads: Should You Be Paying Attention?
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.